Literature DB >> 12759917

Conjoint analysis. The cost variable: an Achilles' heel?

Ulla Slothuus Skjoldborg1, Dorte Gyrd-Hansen.   

Abstract

This paper seeks to enlighten the readers on the potential complexities involved in including cost variables in conjoint analysis, with the aim of emphasising that interpretation of implicit WTP values should be tackled with caution. To illustrate the potential pitfalls, a large data set from a recent Danish study is applied. The data consists of 1991 interviews in which participants are required to perform three discrete choice tasks regarding choice of hospitals, and three choice tasks involving health-care systems in general. Model comparisons are performed which test the effect of (1) the cost range applied and (2) the effect of including a dummy variable to represent the utility associated with payment per se. A wider cost range including higher payments is associated with lower parameter weights associated with the payment variable, and thus increased WTP values. Including a dummy variable to explain utility associated with payment per se has significant effects on the model incurring some of the other variables to become insignificant, and others to change sign. Results suggest that inclusion of a two-dimensional structure to explain the relationship between cost and utility may avoid erroneous conclusions and give rise to significant changes in implicit WTP estimates. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12759917     DOI: 10.1002/hec.742

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  16 in total

1.  What do hospital consultants value about their jobs? A discrete choice experiment.

Authors:  Cristina Ubach; Anthony Scott; Fiona French; Morag Awramenko; Gillian Needham
Journal:  BMJ       Date:  2003-06-28

2.  Validity and Reliability of Willingness-to-Pay Estimates: Evidence from Two Overlapping Discrete-Choice Experiments.

Authors:  Harry Telser; Karolin Becker; Peter Zweifel
Journal:  Patient       Date:  2008-12-01       Impact factor: 3.883

3.  Age and choice in health insurance: evidence from a discrete choice experiment.

Authors:  Karolin Becker; Peter Zweifel
Journal:  Patient       Date:  2008-01-01       Impact factor: 3.883

Review 4.  A 'league table' of contingent valuation results for pharmaceutical interventions: a hard pill to swallow?

Authors:  Tracey H Sach; Richard D Smith; David K Whynes
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

5.  Using discrete choice experiments within a cost-benefit analysis framework: some considerations.

Authors:  Emma McIntosh
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

6.  Preferences of community pharmacists for extended roles in primary care: a survey and discrete choice experiment.

Authors:  Anthony Scott; Christine Bond; Jackie Inch; Aileen Grant
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

7.  Does the inclusion of a cost attribute result in different preferences for the surgical treatment of primary basal cell carcinoma?: a comparison of two discrete-choice experiments.

Authors:  Brigitte A B Essers; Debby van Helvoort-Postulart; Martin H Prins; Martino Neumann; Carmen D Dirksen
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

8.  Preferences for a third-trimester ultrasound scan in a low-risk obstetric population: a discrete choice experiment.

Authors:  Fiona A Lynn; Grainne E Crealey; Fiona A Alderdice; James C McElnay
Journal:  Health Expect       Date:  2013-03-26       Impact factor: 3.377

9.  Conducting discrete choice experiments to inform healthcare decision making: a user's guide.

Authors:  Emily Lancsar; Jordan Louviere
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

10.  A review of the application and contribution of discrete choice experiments to inform human resources policy interventions.

Authors:  Mylene Lagarde; Duane Blaauw
Journal:  Hum Resour Health       Date:  2009-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.